https://www.thebodypro.com/category/prep-hiv-pre-exposure-prophylasxis
HIV Prevention Methods

PrEP (HIV Pre-Exposure Prophylaxis)

The Latest

doctor patient hands
News

This Week in HIV Research: Health in Unity

Jan. 21, 2021: Dyad-level interventions in serodiscordant relationships; using social media to improve PrEP uptake; HCV prevalence among MSM; the irrelevance of doxycycline prophylaxis against mycoplasma genitalium.

By Barbara Jungwirth and Myles Helfand
green light
News

U.S. Waits on Approval of Long-Acting HIV Treatment Cabotegravir and Rilpivirine as European Union Gives the Green Light

The era of once-a-month HIV treatment has begun in the European Union—and it may soon commence in the U.S. as well. Long-acting pre-exposure prophylaxis (PrEP) is also on the horizon.

By Michael Broder
teamwork
News

This Week in HIV Research: Teamwork Makes the Dream Work

Dec. 28, 2020: The power of clinic-pharmacy collaborations; overcoming COVID-19-induced barriers to HIV care; urine testing as a PrEP adherence tool; using incarceration history in PrEP Rx assessments.

By Barbara Jungwirth and Myles Helfand
options
Features

Having More Options Makes PrEP More Viable

PrEP in the form of injections, vaginal rings, or medicated anal douches can give people options that work with their sexual life and desires.

By Juan Michael Porter II
Promo Image
News

This Week in HIV Research: Our Immensely Intersectional Epidemic

Dec. 3, 2020: A simple scoring system for PrEP referral; integrating meth use and HIV prevention interventions; genetically linked HIV strains cross county lines; viral suppression rates in first vs. second pregnancies.

By Barbara Jungwirth and Myles Helfand
intramuscular injection
Features

HIV PrEP Is Finally About to Get Its Shot

PrEP for HIV is a pill. It has always been a pill. But it will not always be a pill, thanks to two major trials evaluating cabotegravir, an integrase inhibitor formulated for intramuscular injection, as PrEP.

By David Alain Wohl, M.D.
prescription bottle
Features

PrEP and Prior Authorization: A Discriminatory Cheap Ploy

An important new analysis describes a key barrier to PrEP in the U.S., one that is almost sinister in its application predominantly in southern states.

By David Alain Wohl, M.D.
chlamydia
Conference Coverage

DoxyPEP for STIs: Are We Ready for Prophylactic Doxycycline for MSM on HIV PrEP?

A recent expert debate explored the pros and cons of prescribing the antibiotic as a preventive measure for a subset of people at especially high risk for sexually transmitted infections.

By Michael Broder
doctor talking to unrecognizable patient
Conference Coverage

For PrEP to Work, Shared Doctor-Patient Decision-Making Is Key

The process of choosing between PrEP options is often not straightforward. Oni Blackstock, M.D., explains how providers can help ensure their patients end up with the most successful option for them.

By Terri Wilder, M.S.W.
Latinx patient
News

‘PrEP for Women Too’ Campaign Aims to Bring This Empowering HIV Prevention Tool to More Black and Latinx Women

Despite PrEP being safe to take for people of all genders, there’s still a lag in uptake among cisgender women.

By Juan Michael Porter II